PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
BRIEF published on 05/13/2025 at 07:35, 1 year 5 months ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
BRIEF published on 05/06/2025 at 07:35, 1 year 5 months ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
BRIEF published on 04/25/2025 at 07:35, 1 year 6 months ago Sensorion's Gene Therapy Presentation at 2025 ASPO Annual Meeting Gene Therapy Clinical Trial Hearing Loss SENS-501 Pediatric Otolaryngology
PRESS RELEASE published on 04/25/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
BRIEF published on 04/18/2025 at 09:29, 1 year 6 months ago Sensorion prepares its General Meeting of May 12, 2025 Shareholders Biotechnology General Meeting Sensorion Hearing Loss
PRESS RELEASE published on 04/18/2025 at 09:24, 1 year 6 months ago Inside Information / Other news releases Sensorion provides preliminary documents for the Combined Shareholders' General Meeting of May 12, 2025 at Hotel Square Louvois, Paris. Shareholders can request meeting documents and view details on company website Shareholders' Meeting General Meeting Preliminary Documents Sensorion Hearing Loss
BRIEF published on 04/16/2025 at 07:35, 1 year 6 months ago Sensorion is organizing a symposium at the ISIET 2025 conference Gene Therapy Hearing Loss SENS-401 Medical Innovations Sensorion Symposium
Published on 11/02/2026 at 17:00, 43 minutes ago PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/02/2026 at 17:00, 43 minutes ago QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
Published on 11/02/2026 at 16:15, 1 hour 28 minutes ago ACCESS Newswire Launches SPOT, Seven AI Agents That Check Every Press Release Before Submission
Published on 11/02/2026 at 15:00, 2 hours 43 minutes ago CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Published on 11/02/2026 at 14:00, 3 hours 43 minutes ago GameSquare to Report Q3 2026 Financial Results on November 16, 2026
Published on 11/02/2026 at 17:30, 13 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 11/02/2026 (French only)
Published on 11/02/2026 at 16:00, 1 hour 43 minutes ago Shares Admitted to Trading and Total Voting Rights
Published on 11/02/2026 at 15:58, 1 hour 45 minutes ago Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 11/02/2026 at 15:19, 2 hours 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/02/2026 at 15:19, 2 hours 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/02/2026 at 15:25, 2 hours 18 minutes ago Guillemot Corporation S.A. | Information regarding the total number of voting rights and shares 31/10/2026
Published on 10/30/2026 at 23:00, 2 days 18 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 23 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 3 days 5 hours ago Capital increase through exercise of subscription rights
